Authors: Steg, PG Grollier, G Gallay, P Morice, MC Karrillon, GJ Benamer, H Kempf, C Laperche, T Arnaud, P Sellier, P Bourguignon, C Harpey, C

Citation: Pg. Steg et al., A randomized double-blind trial of intravenous trimetazidine as adjunctivetherapy to primary angioplasty for acute myocardial infarction, INT J CARD, 77(2-3), 2001, pp. 263-273

Authors: Steg, PG Laperche, T Karila-Cohen, D

Citation: Pg. Steg et al., Value of trimetazidine as an adjunctive therapy to primary PTCA for acute myocardial infarction, EUR H J SUP, 1(O), 1999, pp. O19-O23

Authors: Laperche, T Logeart, D Cohen-Solal, A Gourgon, R

Citation: T. Laperche et al., Potential interests of heart rate lowering drugs, HEART, 81(4), 1999, pp. 336-341

Authors: Lagneau, F Beyne, P Letteron, P Laperche, T Marty, J

Citation: F. Lagneau et al., Fluid therapy directly interferes with immunoassay for cardiac troponin I, INTEN CAR M, 25(6), 1999, pp. 625-627

Authors: Pateron, D Beyne, P Laperche, T Logeard, D Lefilliatre, P Sogni, P Moreau, R Langlet, P Elman, A Bernuau, J Valla, D Erlinger, S Lebrec, D

Citation: D. Pateron et al., Elevated circulating cardiac troponin I in patients with cirrhosis, HEPATOLOGY, 29(3), 1999, pp. 640-643